Analysis of hepatitis C virus (HCV) RNA load in platelets of HCV-monoinfected patients receiving antiviral therapy

Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 3

Abstract

[b]Introduction[/b]. Detection of hepatitis C virus (HCV) has been reported in extrahepatic sites such as peripheral blood mononuclear cells and platelets. Quantitation of HCV-RNA in platelets from patients under antiviral therapy has not been reported. [b]Material and methods[/b]. HCV-RNA levels in paired serum and platelet samples of 17 chronically HCV-infected patients were determined at baseline, week 12, end-of-treatment, and 24 weeks after completion of treatment with pegylated interferon plus ribavirin. Quantitation of HCVRNA load was performed using COBAS® TaqMan® HCV Test v 2.0 (lower limit of detection, 25 IU/mL). The cohort predominantly consisted of female (59%) with a mean age of 50.7 ± 10.0 years. [b]Results[/b]. Measurements of HCV-RNA in relation to different timepoints of therapy revealed baseline viral load was most frequently detected in higher levels in serum than in platelets (5.6 x 104 IU/mL vs. 379.0 IU/mL; p = 0.0002), a trend also demonstrated in most samples throughout the study. HCV-RNA was also found at low levels (< 25.0-314.0 UI/mL) persistently in platelets of three patients who have lost detectable HCV-RNA in serum during antiviral therapy, resulting in virological relapse. [b]Conclusion[/b]. HCV-RNA levels are most frequently detected in higher levels in serum than in platelets, independent of timepoint of antiviral therapy. Further studies with an increase in size of the samples are needed to better evaluate whether or not patients who presented HCV-RNA at low levels in platelets after having lost detectable HCV-RNA in serum during antiviral therapy are at increased risk of relapse of HCV infection during follow-up evaluation.

Authors and Affiliations

Márcia do Espírito-Santo, Carlos Brandão-Mello, Vanessa Marques, Elisabeth Lampe, Adilson De Almeida

Keywords

Related Articles

Indications for treatment in chronic HCV infection

HCV Infection is a global burden disease and it is related to the development of progressive liver fibrosis, cirrhosis and hepatocellular carcinoma. At least 80% of the persons that have an acute infection evolve to chro...

Contrast-induced acute kidney injury in cirrhotic patients. A retrospective analysis

Background. The nephrotoxic potential of intravenous iodinated contrast (IC) is controversial. Cirrhotic patients are often submitted to imaging procedures involving IC and small changes in renal function may have detrim...

Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice

Background and aims. Entecavir (ETV) is effective and safe in patients with chronic hepatitis B in the short term, but its long term efficacy and safety has not been established. Material and methods. We evaluated HBV DN...

Dorsal root ganglionopathy in a hepatitis C patient: a case report

We report an unusual clinical presentation of dorsal root ganglionopathy in a hepatitis C patient with negative cryoglobulins characterized by both motor and sensory symptoms. This mixed clinical picture in a hepatitis C...

Complications of liver resection in geriatric patients

Introduction and aims. Liver resection is the treatment of choice for many primary and secondary liver diseases. Most studiesin the elderly have reported resection of primary and secondary liver tumors, especially hepat...

Download PDF file
  • EP ID EP78276
  • DOI -
  • Views 135
  • Downloads 0

How To Cite

Márcia do Espírito-Santo, Carlos Brandão-Mello, Vanessa Marques, Elisabeth Lampe, Adilson De Almeida (2013). Analysis of hepatitis C virus (HCV) RNA load in platelets of HCV-monoinfected patients receiving antiviral therapy. Annals of Hepatology, 12(3), 373-379. https://europub.co.uk/articles/-A-78276